Biograph Vision vs FFRangio System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Siemens Healthineers
VS
by CathWorks (acquired by Medtronic)

AI Verdict

These tools are adjacent in the cardiology AI space but serve distinct purposes. Biograph Vision is a comprehensive PET/CT imaging system focused on multi-specialty diagnostics, including cardiology, by providing high-resolution anatomical and metabolic insights. In contrast, the FFRangio System is an interventional guidance tool specifically designed for coronary artery disease, using AI to provide wire-free FFR values to optimize PCI decisions.

Choose Biograph Vision if…

Choose Biograph Vision if your primary need is highly precise and efficient diagnostic imaging across oncology, cardiology, and neurology. This PET/CT system excels at providing detailed anatomical and metabolic information with reduced scan times and lower patient dose, making it ideal for comprehensive disease staging, treatment response assessment, and challenging cases requiring superior image quality and motion correction.

View Biograph Vision →

Choose FFRangio System if…

Choose FFRangio System if you require a less invasive and more efficient method for functional assessment of coronary artery disease in the cath lab. This system provides real-time, wire-free FFR guidance and advanced insights to optimize percutaneous coronary intervention (PCI) decisions, streamlining procedures and reducing the need for invasive pressure wires and pharmacological stress agents.

View FFRangio System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Biograph Vision FFRangio System
Pricing Unknown Contact vendor for pricing information.
Deployment On-premise (medical imaging system) SaaS, on-prem, hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FFRangio System

The FFRangio System offers a highly intuitive user interface and significantly enhances patient and clinician experience by eliminating the need for invasive pressure wires, drugs, or guide catheters. This wire-free and drug-free approach streamlines the procedural workflow and reduces invasiveness for patients. While Biograph Vision improves patient comfort with a large bore and reduces scan times, FFRangio's direct impact on making a procedure less invasive and simplifying the clinician's interaction gives it an edge in usability.

Clinical Value

FFRangio System

The FFRangio System provides accurate multi-vessel FFR results and advanced insights for optimizing PCI decisions, with demonstrated excellent diagnostic accuracy and comparable clinical outcomes to invasive FFR in randomized controlled trials and real-world registries. This direct evidence of non-inferiority to the gold standard for guiding treatment decisions highlights its strong clinical utility. Biograph Vision offers high-resolution imaging for precise diagnostics across multiple specialties, but FFRangio's proven impact on treatment outcomes is a more direct measure of clinical value.

Pricing & Value

FFRangio System

Both tools require direct vendor contact for pricing, indicating a lack of transparency. However, the FFRangio System explicitly offers economic advantages by eliminating the need for expensive invasive pressure wires, drugs, and guide catheters, and by reducing procedure time and resource utilization in the cath lab. While Biograph Vision can reduce scan times and patient dose, the direct and quantifiable cost savings from eliminating consumables and shortening procedures give FFRangio a clearer value proposition.

Enterprise Readiness

FFRangio System

Both are FDA-cleared, on-premise medical devices. The FFRangio System is ISO 27001 certified for information security, which is a strong, verifiable standard for handling protected health information within an enterprise environment. It also emphasizes seamless integration with existing cath lab equipment and PACS. While Siemens Healthineers (Tool A) is a large, established vendor, FFRangio's explicit ISO 27001 certification provides a concrete advantage in demonstrating readiness for secure data management.

Innovation

FFRangio System

The FFRangio System represents a significant paradigm shift by offering wire-free and drug-free 3D FFR guidance, leveraging AI and computational science to provide physiological information from routine angiograms. This fundamentally changes a previously invasive diagnostic procedure. Biograph Vision also showcases innovation with advanced detector technology and AI-powered workflows for superior PET/CT imaging, but FFRangio's disruptive approach to a core cardiology procedure stands out as a more transformative innovation.

Support & Docs

Biograph Vision

Siemens Healthineers, as a major global medical device manufacturer, provides extensive support and documentation for Biograph Vision, including operator and service manuals, site readiness guides, classroom training, on-site workshops, and e-learning resources via PEPconnect. This comprehensive infrastructure for training and ongoing support is typically more robust than that offered by smaller, albeit innovative, companies. While FFRangio provides instructions for use and educational symposia, the breadth of Siemens' established support system is superior.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Biograph Vision FFRangio System
Product Name Biograph Vision FFRangio System
Company Siemens Healthineers CathWorks
Primary Function PET/CT imaging system for precise diagnostics in oncology, cardiology, and neurology, aiming to reduce scan times and patient dose. Wire-free and drug-free 3D FFR guidance for optimizing and confirming PCI decisions in coronary artery disease.
Tagline Bigger perspective. Better answers. Redefine PET/CT imaging with precision-driven performance. A New Era in Coronary Physiology
Key Application Areas Cardiology AI, Oncology AI, Radiology & Imaging AI Cardiology AI, Surgical AI

Videos

Demos, reviews, and walkthroughs featuring Biograph Vision and FFRangio System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Biograph Vision PET/CT system is designed for precise diagnostics in oncology, cardiology, and neurology, aiming to reduce scan times and patient dose. The FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease.
The Biograph Vision aims to enhance patient comfort with a 78-cm large bore and reduce scan times (as low as 3 minutes for whole-body scans) and injected radiopharmaceutical dose. The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter, offering a wire-free and drug-free approach to FFR guidance.
The Biograph Vision offers high-resolution PET/CT images with features like Optiso Ultra Dynamic Range (UDR) detector technology, 3.2-mm LSO crystals, 214-ps true time-of-flight (TOF) performance, and motion correction (OncoFreeze, CardioFreeze). The FFRangio System delivers real-time FFRangio values at every point on the coronary tree, a simulated pullback curve to differentiate functional patterns of CAD, and a Lesion Impact feature to assess residual ischemia, along with an integrated sizing tool for non-invasive lesion measurements.
Both systems are on-premise deployments; the Biograph Vision is a physical medical device that can fit into existing PET/CT scanner rooms. The FFRangio System integrates seamlessly with cath lab equipment, C-arm angiography systems, and PACS.
The Biograph Vision is designed for reduced scan times, with whole-body scans as low as 3 minutes, and aims to boost productivity and throughput. The FFRangio System uses artificial intelligence to aid in quick angiogram analysis and provides advanced insights to quickly optimize and confirm PCI decisions, streamlining procedural workflow.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.